Prothera Biologics, Inc.
Providence, RI
- UEI
- ZAE3CABBMZE9
- CAGE
- 47QA1
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 349 Eddy St, Providence, RI 02903, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Inter-alpha inhibitors in experimental necrotizing enterocolitis - necrotizing enterocolitis (NEC) is a devastating… | National Institute of Child Health and Human Development | $428,456 | |
| Rapid test to assist therapy in neonatal sepsis and necrotizing enterocolitis | National Institute of Allergy and Infectious Diseases | $7,870,848 | |
| Therapeutic role of inter-alpha inhibitors in wound healing | National Institutes of Health | $224,688 | |
| Inter-alpha-inhibitors in hypoxic-ischemic brain injury | National Institutes of Health | $203,226 | |
| Inter-alpha inhibitors in hypoxic-ischemic brain injury | National Institute of Neurological Disorders and Stroke | $4,702,535 |
Quick answers
What is Prothera Biologics, Inc.'s UEI?
Prothera Biologics, Inc.'s Unique Entity ID (UEI) in SAM.gov is ZAE3CABBMZE9.
What is Prothera Biologics, Inc.'s CAGE code?
Prothera Biologics, Inc.'s CAGE code is 47QA1.
What is Prothera Biologics, Inc.'s primary NAICS code?
Prothera Biologics, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Prothera Biologics, Inc. located?
Prothera Biologics, Inc.'s physical address in SAM.gov is 349 Eddy St, Providence, RI 02903, USA.
Is Prothera Biologics, Inc. registered in SAM.gov?
Prothera Biologics, Inc.'s SAM.gov registration expired on October 8, 2026.
What is Prothera Biologics, Inc.'s most recent federal award?
Prothera Biologics, Inc.'s most recent federal grant award is Inter-alpha inhibitors in experimental necrotizing enterocolitis - necrotizing enterocolitis (NEC) is a devastating… (R43HD114348), from National Institute of Child Health and Human Development, on September 22, 2023.
On GovTribe
See Prothera Biologics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors